Cargando…

Screening for comorbidities in COPD

Due to growing recognition of comorbidities, COPD is no longer considered a disease affecting only the respiratory system. Its management now entails the early diagnosis and treatment of comorbidities. However, although many studies have examined the impact of comorbidities on the evolution of COPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Natali, Delphine, Cloatre, Georges, Hovette, Philippe, Cochrane, Belinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249790/
https://www.ncbi.nlm.nih.gov/pubmed/32494303
http://dx.doi.org/10.1183/20734735.0315-2019
_version_ 1783538657069629440
author Natali, Delphine
Cloatre, Georges
Hovette, Philippe
Cochrane, Belinda
author_facet Natali, Delphine
Cloatre, Georges
Hovette, Philippe
Cochrane, Belinda
author_sort Natali, Delphine
collection PubMed
description Due to growing recognition of comorbidities, COPD is no longer considered a disease affecting only the respiratory system. Its management now entails the early diagnosis and treatment of comorbidities. However, although many studies have examined the impact of comorbidities on the evolution of COPD and patients’ quality of life, very few have explored the means to systematically identify and manage them. The aims of this article are to summarise the state of current knowledge about comorbidities associated with COPD and to propose a possible screening protocol in the outpatient setting, emphasising the areas needing further research.
format Online
Article
Text
id pubmed-7249790
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-72497902020-06-02 Screening for comorbidities in COPD Natali, Delphine Cloatre, Georges Hovette, Philippe Cochrane, Belinda Breathe (Sheff) Reviews Due to growing recognition of comorbidities, COPD is no longer considered a disease affecting only the respiratory system. Its management now entails the early diagnosis and treatment of comorbidities. However, although many studies have examined the impact of comorbidities on the evolution of COPD and patients’ quality of life, very few have explored the means to systematically identify and manage them. The aims of this article are to summarise the state of current knowledge about comorbidities associated with COPD and to propose a possible screening protocol in the outpatient setting, emphasising the areas needing further research. European Respiratory Society 2020-03 /pmc/articles/PMC7249790/ /pubmed/32494303 http://dx.doi.org/10.1183/20734735.0315-2019 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Reviews
Natali, Delphine
Cloatre, Georges
Hovette, Philippe
Cochrane, Belinda
Screening for comorbidities in COPD
title Screening for comorbidities in COPD
title_full Screening for comorbidities in COPD
title_fullStr Screening for comorbidities in COPD
title_full_unstemmed Screening for comorbidities in COPD
title_short Screening for comorbidities in COPD
title_sort screening for comorbidities in copd
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249790/
https://www.ncbi.nlm.nih.gov/pubmed/32494303
http://dx.doi.org/10.1183/20734735.0315-2019
work_keys_str_mv AT natalidelphine screeningforcomorbiditiesincopd
AT cloatregeorges screeningforcomorbiditiesincopd
AT hovettephilippe screeningforcomorbiditiesincopd
AT cochranebelinda screeningforcomorbiditiesincopd